openPR Logo
Press release

Global Male Infertility Treatment Market Insights, Forecast

04-25-2019 10:27 AM CET | Health & Medicine

Press release from: Market Density

Global Male Infertility Treatment Market Insights, Forecast

According to Word Health Organization, ‘Infertility is the inability of a sexually active, non-contraception couple to achieve pregnancy in one year’. About 15% of couples do not achieve pregnancy within 1year and seeking for infertility medical treatment. Less than 5% of world population is unwillingly childless. Approximately 90% of male infertility cases are seen mainly due to low sperm counts, and poor sperm quality. The remaining cases of male infertility can be caused by a number of factors including anatomical problems, hormonal imbalances, and genetic defects. The global Male Infertility Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Male Infertility Treatment market based on company, product type, end user and key regions. This report studies the global market size of Male Infertility Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Male Infertility Treatment in these regions. This research report categorizes the global Male Infertility Treatment market by top players/brands, region, type and end user. This report also studies the global Male Infertility Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: EMD Sereno Aytu BioScience Bayer Cadila Intas Pharma Halotech DNA SCSA diagnostics Andrology Solutions Market size by Product DNA Fragmentation Technique Oxidative Stress Analysis Microscopic Examination Sperm Agglutination Computer Assisted Semen Analysis Sperm Penetration Assay Others Market size by End User Hospitals Clinics Others Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Male Infertility Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Male Infertility Treatment market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Male Infertility Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Male Infertility Treatment submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Male Infertility Treatment are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Male Infertility Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=122169

Table of Contents:

Table of Contents

1 Study Coverage
1.1 Male Infertility Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Male Infertility Treatment Market Size Growth Rate by Product
1.4.2 DNA Fragmentation Technique
1.4.3 Oxidative Stress Analysis
1.4.4 Microscopic Examination
1.4.5 Sperm Agglutination
1.4.6 Computer Assisted Semen Analysis
1.4.7 Sperm Penetration Assay
1.4.8 Others
1.5 Market by End User
1.5.1 Global Male Infertility Treatment Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Male Infertility Treatment Market Size
2.1.1 Global Male Infertility Treatment Revenue 2014-2025
2.1.2 Global Male Infertility Treatment Sales 2014-2025
2.2 Male Infertility Treatment Growth Rate by Regions
2.2.1 Global Male Infertility Treatment Sales by Regions
2.2.2 Global Male Infertility Treatment Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Male Infertility Treatment Sales by Manufacturers
3.1.1 Male Infertility Treatment Sales by Manufacturers
3.1.2 Male Infertility Treatment Sales Market Share by Manufacturers
3.1.3 Global Male Infertility Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Male Infertility Treatment Revenue by Manufacturers
3.2.1 Male Infertility Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Male Infertility Treatment Revenue Share by Manufacturers (2014-2019)
3.3 Male Infertility Treatment Price by Manufacturers
3.4 Male Infertility Treatment Manufacturing Base Distribution, Product Types
3.4.1 Male Infertility Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Male Infertility Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Male Infertility Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Male Infertility Treatment Sales by Product
4.2 Global Male Infertility Treatment Revenue by Product
4.3 Male Infertility Treatment Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Male Infertility Treatment Breakdown Data by End User

6 North America
6.1 North America Male Infertility Treatment by Countries
6.1.1 North America Male Infertility Treatment Sales by Countries
6.1.2 North America Male Infertility Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Male Infertility Treatment by Product
6.3 North America Male Infertility Treatment by End User

7 Europe
7.1 Europe Male Infertility Treatment by Countries
7.1.1 Europe Male Infertility Treatment Sales by Countries
7.1.2 Europe Male Infertility Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Male Infertility Treatment by Product
7.3 Europe Male Infertility Treatment by End User

8 Asia Pacific
8.1 Asia Pacific Male Infertility Treatment by Countries
8.1.1 Asia Pacific Male Infertility Treatment Sales by Countries
8.1.2 Asia Pacific Male Infertility Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Male Infertility Treatment by Product
8.3 Asia Pacific Male Infertility Treatment by End User

9 Central & South America
9.1 Central & South America Male Infertility Treatment by Countries
9.1.1 Central & South America Male Infertility Treatment Sales by Countries
9.1.2 Central & South America Male Infertility Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Male Infertility Treatment by Product
9.3 Central & South America Male Infertility Treatment by End User

10 Middle East and Africa
10.1 Middle East and Africa Male Infertility Treatment by Countries
10.1.1 Middle East and Africa Male Infertility Treatment Sales by Countries
10.1.2 Middle East and Africa Male Infertility Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Male Infertility Treatment by Product
10.3 Middle East and Africa Male Infertility Treatment by End User

11 Company Profiles
11.1 EMD Sereno
11.1.1 EMD Sereno Company Details
11.1.2 Company Business Overview
11.1.3 EMD Sereno Male Infertility Treatment Sales, Revenue and Gross Margin (2014-2019)
11.1.4 EMD Sereno Male Infertility Treatment Products Offered
11.1.5 EMD Sereno Recent Development
11.2 Aytu BioScience
11.2.1 Aytu BioScience Company Details
11.2.2 Company Business Overview
11.2.3 Aytu BioScience Male Infertility Treatment Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Aytu BioScience Male Infertility Treatment Products Offered
11.2.5 Aytu BioScience Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Business Overview
11.3.Bayer Male Infertility Treatment Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bayer Male Infertility Treatment Products Offered
11.3.5 Bayer Recent Development
11.4 Cadila
11.4.1 Cadila Company Details
11.4.2 Company Business Overview
11.4.3 Cadila Male Infertility Treatment Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Cadila Male Infertility Treatment Products Offered
11.4.5 Cadila Recent Development
11.5 Intas Pharma
11.5.1 Intas Pharma Company Details
11.5.2 Company Business Overview
11.5.3 Intas Pharma Male Infertility Treatment Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Intas Pharma Male Infertility Treatment Products Offered
11.5.5 Intas Pharma Recent Development
11.6 Halotech DNA
11.6.1 Halotech DNA Company Details
11.6.2 Company Business Overview
11.6.3 Halotech DNA Male Infertility Treatment Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Halotech DNA Male Infertility Treatment Products Offered
11.6.5 Halotech DNA Recent Development
11.7 SCSA diagnostics
11.7.1 SCSA diagnostics Company Details
11.7.2 Company Business Overview
11.7.3 SCSA diagnostics Male Infertility Treatment Sales, Revenue and Gross Margin (2014-2019)
11.7.4 SCSA diagnostics Male Infertility Treatment Products Offered
11.7.5 SCSA diagnostics Recent Development
11.8 Andrology Solutions
11.8.1 Andrology Solutions Company Details
11.8.2 Company Business Overview
11.8.3 Andrology Solutions Male Infertility Treatment Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Andrology Solutions Male Infertility Treatment Products Offered
11.8.5 Andrology Solutions Recent Development

12 Future Forecast
12.1 Male Infertility Treatment Market Forecast by Regions
12.1.1 Global Male Infertility Treatment Sales Forecast by Regions 2019-2025
12.1.2 Global Male Infertility Treatment Revenue Forecast by Regions 2019-2025
12.2 Male Infertility Treatment Market Forecast by Product
12.2.1 Global Male Infertility Treatment Sales Forecast by Product 2019-2025
12.2.2 Global Male Infertility Treatment Revenue Forecast by Product 2019-2025
12.3 Male Infertility Treatment Market Forecast by End User
12.4 North America Male Infertility Treatment Forecast
12.5 Europe Male Infertility Treatment Forecast
12.6 Asia Pacific Male Infertility Treatment Forecast
12.7 Central & South America Male Infertility Treatment Forecast
12.8 Middle East and Africa Male Infertility Treatment Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Male Infertility Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-male-infertility-treatment-market-insights-forecast

About Market Density:

Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:

Email: sales@marketdensity.com

Website: www.marketdensity.com

Phone: +1 669 264 1656

4340 Stevens Creek Blvd,
Suite # 172,
San Jose, CA 95129

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Male Infertility Treatment Market Insights, Forecast here

News-ID: 1717628 • Views: 189

More Releases from Market Density

Global Product Management Software Market Size, Status and Forecast
This report focuses on the global Product Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Product Management Software development in United States, Europe and China. In 2017, the global Product Management Software market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players
Global Computer Aided Engineering (CAE) Market Size, Status and Forecast
This report focuses on the global Computer Aided Engineering (CAE) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computer Aided Engineering (CAE) development in United States, Europe and China. Computer-aided engineering is the broad usage of computer software to aid in engineering analysis tasks. In regard to information networks, CAE systems are individually considered a single node on a total information
Global Computerized Numerical Control Market Size, Status and Forecast
This report focuses on the global Computerized Numerical Control status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computerized Numerical Control development in United States, Europe and China. Computer numerical control (CNC) is the automation of machine tools by means of computers executing pre-programmed sequences of machine control commands. The key factor contributing to the computerized numerical control market is the growth
Global Connected Retail Market Size, Status and Forecast
This report focuses on the global Connected Retail status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Connected Retail development in United States, Europe and China. A Connected Retail strategy allows people to use the strength of the network to connect the brands to today's consumers. Connected Retail can help collaborate more effectively with employees and field managers, maintain security vigilance and

All 5 Releases


More Releases for Infertility

Women Infertility Market Pipeline Review, H2 2017
"The Report Women Infertility - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2017, provides an overview of the Women Infertility (Women's Health) pipeline landscape. Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due
Infertility Services Market in US
Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy. Research analysts forecast the infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021. Request sample copy of the report at:
Global Infertility Drug Pipeline Analysis
The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing
Female Infertility-Pipeline Insights, 2017
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Female Infertility-Pipeline Insights, 2017 “Female Infertility-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Female Infertility. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III
Male Infertility - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Male Infertility - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Male Infertility – Pipeline Review, H1 2017, provides an overview of the Male Infertility (Male Health) pipeline landscape. Male infertility refers to a male's inability to achieve a pregnancy in a fertile female. Male infertility is
Infertility Services Market in US 2017-2021
Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy. Technavios analysts forecast the infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021. Covered in this report The report covers the